Table of contents
Volume 93, Issue 4
Published online 16 August 2005 (385-498)
Guidelines |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Book Review
Editorial
REporting recommendations for tumour MARKer prognostic studies (REMARK) FREE
A L Harris
Br J Cancer 93: 385-386; doi:10.1038/sj.bjc.6602730
Guidelines
REporting recommendations for tumour MARKer prognostic studies (REMARK) FREE
L M McShane, D G Altman, W Sauerbrei, S E Taube, M Gion and G M Clark for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Br J Cancer 93: 387-391; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602678
Clinical Studies
Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study FREE
W Chen, D B Petitti and A M Geiger
Br J Cancer 93: 392-398; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602701
Clinical features of colorectal cancer before diagnosis: a population-based case–control study FREE
W Hamilton, A Round, D Sharp and T J Peters
Br J Cancer 93: 399-405; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602714
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study FREE
P F Conte, S Donati, A Gennari, V Guarneri, C Orlandini, M Rondini, M Roncella, L Marini, P Collecchi, P Viacava, A G Naccarato, R Degli Esposti, S Bonardi, A Bottini, S Saracchini, S Tumolo, G Gullo, A Santoro and L Crino
Br J Cancer 93: 406-411; advance online publication, July 26, 2005; doi:10.1038/sj.bjc.6602723
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours FREE
U De Giorgi, G Rosti, S Slavin, I Yaniv, J L Harousseau, R Ladenstein, T Demirer and G Dini on behalf of the European Group for Blood and Marrow Transplantation Solid Tumours and Paediatric Disease Working Parties
Br J Cancer 93: 412-417; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602724
Second primary malignancies after treatment for malignant lymphoma FREE
A Okines, C S Thomson, C R Radstone, J M Horsman and B W Hancock
Br J Cancer 93: 418-424; doi:10.1038/sj.bjc.6602731
Translational Therapeutics
Angiotensin II directly induces muscle protein catabolism through the ubiquitin–proteasome proteolytic pathway and may play a role in cancer cachexia FREE
P M Sanders, S T Russell and M J Tisdale
Br J Cancer 93: 425-434; advance online publication, July 26, 2005; doi:10.1038/sj.bjc.6602725
Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response FREE
K Ivarsson, L Myllymäki, K Jansner, U Stenram and K-G Tranberg
Br J Cancer 93: 435-440; advance online publication, August 9, 2005; doi:10.1038/sj.bjc.6602718
Adenovirus-mediated interferon 
gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer FREE
M Ohashi, K Yoshida, M Kushida, Y Miura, S Ohnami, Y Ikarashi, Y Kitade, T Yoshida and K Aoki
Br J Cancer 93: 441-449; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602713
Molecular Diagnostics
Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung FREE
F Barlési, D Pinot, A LeGoffic, C Doddoli, B Chetaille, J-P Torre and P Astoul
Br J Cancer 93: 450-452; advance online publication, July 26, 2005; doi:10.1038/sj.bjc.6602717
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer FREE
L Boldrini, V Donati, M Dell'Omodarme, M C Prati, P Faviana, T Camacci, M Lucchi, A Mussi, M Santoro, F Basolo and G Fontanini
Br J Cancer 93: 453-457; advance online publication, August 9, 2005; doi:10.1038/sj.bjc.6602715
TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma FREE
Y-H Yin, Y-Y Li, H Qiao, H-C Wang, X-A Yang, H-G Zhang, X-W Pang, Y Zhang and W-F Chen
Br J Cancer 93: 458-463; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602716
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas FREE
P Pallante, M T Berlingieri, G Troncone, M Kruhoffer, T F Orntoft, G Viglietto, A Caleo, I Migliaccio, M Decaussin-Petrucci, M Santoro, L Palombini and A Fusco
Br J Cancer 93: 464-471; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602721
The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers FREE
D A Lawes, T Pearson, S SenGupta and P B Boulos
Br J Cancer 93: 472-477; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602708
Construction of tissue microarrays from prostate needle biopsy specimens FREE
S Jhavar, C M Corbishley, D Dearnaley, C Fisher, A Falconer, C Parker, R Eeles and C S Cooper
Br J Cancer 93: 478-482; advance online publication, August 9, 2005; doi:10.1038/sj.bjc.6602726
Genetics and Genomics
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles FREE
L Rickardson, M Fryknäs, S Dhar, H Lövborg, J Gullbo, M Rydåker, P Nygren, M G Gustafsson, R Larsson and A Isaksson
Br J Cancer 93: 483-492; advance online publication, July 12, 2005; doi:10.1038/sj.bjc.6602699
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk FREE
F Lindmark, S L Zheng, F Wiklund, K A Bälter, J Sun, B Chang, M Hedelin, J Clark, J-E Johansson, D A Meyers, H-O Adami, W Isaacs, H Grönberg and J Xu
Br J Cancer 93: 493-497; advance online publication, August 2, 2005; doi:10.1038/sj.bjc.6602729
Book Review
Blood lines FREE
T R J Lappin
Br J Cancer 93: 498; doi:10.1038/sj.bjc.6602727
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
